Article History
Accepted: 17 January 2024
First Online: 29 February 2024
Competing interests
: R.J. is a paid consultant for NextRNA and inventor of the patent ‘Nucleic acid agents for treatment of non-small-cell lung cancer’ (WO2023061888A1). S.O. is CEO, founder and shareholder of HAYA Therapeutics SA. The other authors declare no competing interests.